HKSH November lecture





Recent Advancement in Minimal Residual Disease Detection in Multiple Myeloma and Its Clinical Implication


Date: 20 Nov 2019 (Wednesday)

Time: 6:30 pm -10:00 pm

Venue: Chatham Room, Level 7, Conrad Hong Kong

Speaker: Dr. María-Victoria Mateos, MD, PhD   

Associate Professor, Medicine Department, University of Salamanca
Director, Myeloma Program, University Hospital of Salamanca


Chairperson: Dr. Law Man Fai, Specialist in Haematology and Haematological Oncology



6:30 pm - 7:15 pm          Reception

7:15 pm - 8:15 pm          Lecture

8:15 pm - 8:30 pm          Q&A

8:30 pm                         Dinner


RSVP: Ms. Denise Kwan at 2736 1926 (fax) or (email)


Or  Register at




CME point – Hong Kong College of Physicians, Pathologists and Radiologists (under application).


Summary of symposium

Practical considerations of minimal residual disease (MRD) assessment methods in multiple myeloma (MM) (methods, when and frequency to monitor, pros and cons)

Importance of MRD in MM (correlation to treatment outcome)

Clinical implication of MRD in MM currently and in the future (e.g. its value in informing prognosis, patient stratifications, role in informing treatment choice and stopping criteria)